Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 23 (2) , 70-75
- https://doi.org/10.1159/000059706